Impact of treatment efficacy and dosing frequency on cost-effectiveness of bisphosphonate treatment for osteoporosis: a perspective

By Boonen Steven  

Current Medical Research and Opinion, Vol. 25, Iss. 10, 2009-10 ,pp. : 2335-2341

Informa Healthcare

Access to resources Recommend Favorite

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)

By Cooper C.   Reginster J.-Y.   Cortet B.   Diaz-Curiel M.   Lorenc R.S.   Kanis J.A.   Rizzoli R.  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 475-491

Informa Healthcare

Access to resources Recommend Favorite

The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden

By Zethraeus N.   Ström O.   Borgström F.   Kanis J.   Jönsson B.  

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 819-827

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women

By Kanis J.   Borgstrom F.   Johnell O.   Jonsson B.  

Osteoporosis International, Vol. 15, Iss. 11, 2004-11 ,pp. : 862-871

Springer Publishing Company

Access to resources Recommend Favorite

Long dosing intervals in the treatment of postmenopausal osteoporosis

By Lewiecki E. Michael  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2617-2625

Informa Healthcare

Access to resources Recommend Favorite